[] Imamura, K, Y Tsuyama, T Hirata, et al. Identification and characterization of a novel fermented substance produced by edible Aspergillus oryzae AO-1 that inhibits DPP-IV activity[J]. Biosci Bioeng, 2011, 111(1): 37-40. DOI: 10.1016/j.jbiosc.2010.08.013.[] Mazziotti, G, C Gazzaruso, A Giustina, et al. Diabetes in Cushing syndrome: basic and clinical aspects[J]. Trends Endocrinol Metab, 2011, 22(12): 499-506. DOI: 10.1016/j.tem.2011.09.001[] Xu J, Lian F, Zhao L, et al. Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula[J]. Int Soc Microb Ecol, 2015, 9: 552–562. DOI: 10.1038/ismej.2014.177.[] Mukherjee A, Sengupta S. Indian medicinal plants known to contain intestinal glucosidase inhibitors also inhibit pancreatic lipase activity-an ideal situation for obesity control by drugs[J]. Indian J. Biotech, 2013, 12: 32–39.[] Wang WD, Xu TJ, Chen WP. The meta-analysis about the combination of α-glycosi-dase enzyme inhibitors and metform in for treating type 2 dia-betes. Chin J Clin Health C, 2008, 11: 572-573.[] Seifarth C, Bergmann J, Holst JJ, Ritzel R, Schmiegel W and Nauck MA. Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to a-glucosidase inhibition (acarbose) in type 2 diabetic patients[J]. Diabetic Medicine, 1998, 15: 485-491. DOI: 10.1002/(SICI)1096[] Jing C, Cheng Y Q, Yamaki K, et al. Anti-a-glucosidase activity of Chinese traditionally fermented soybean (douchi)[J]. Food Chem, 2007, 103(4): 1091-1096. DOI.org/10.1016/j.foodchem.2006.10.003[] Chen P, Zhang Q, Dang H, et al. Oral administration of Lactobacillus rhamnosus CCFM0528 improves glucose tolerance and cytokine secretion in high-fat-fed, streptozotocin-induced type 2 diabetic mice[J]. Function Foods. 2014, 10(9): 318–326. DOI: 10.1016/j.jff.2014.06.014[] Ejtahed H S, Mohtadi Nia J, Homayouni Rad A, et al. Probiotic yogurt improves antioxidant status in type 2 diabetic patients[J]. Nutrition, 2012, 28(5): 539-543. DOI.org/10.1016/j.nut.2011.08.013[] He Qiuwen. Study on preventive and theraputic effect of probiotic Lactobacillus casei Zhang on type 2 diabetes in rats[D]. Wuxi: University Of The South, 2012: 35.[] Tian Peijun. Lactbacillius G15 and Q14 alleviates type 2 diabetes in association with regulation of gut microflora in rats[D]. Harbin: Harbin Institute of Technology, 2016: 49.[] Moroti C, Magri L F S, Costa M D R, et al. Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus[J]. Lipids in Health & Disease, 2012, 11(4): 29. DOI: 10.1186/1476-511X-11-29[] Chen Pei, Dang Hui, Zhang Qiuxiang, Zhang Hao, et al. Screening for Potential New Probiotic Based on Anti diabetic Effect[J]. Chinese Institute of Food Science and Technology, 2014, 14(11): 27-33.[] FAO,WHO.Report of a joint FAO/WHO expert consultation on evaluation of health and nutritional proper ties of probiotics in food including powder milk with live lactic acid bacteria[M]. Coraoba: Argentina, 2001.[] Del Piano M, Morelli L, Strozzi G P, et al. Probiotics: from research to consumer[J]. Digestive and Liver Disease, 2006, 38(2): 248-255. DOI.org/10.1016/S1590-8658(07)60004-8[] Vasiljevic T, Shah N P, Probiotics-From Metchnikoff to bioactives[J]. International Dairy Journal, 2008, 18(7): 714-728. DOI.org/10.1016/j.idairyj.2008.03.004[] Eng-Seng Chan, Peh-Phong Lee, Pogaku Ravindra, et al. A Standard Quantitative Method to Measure Acid Tolerance of Probiotic cells[J]. Appl Microbiol Biotechnol,2010, 86: 385-391. DOI:10.1007/s00253-009-2384-y[] GB/T 4789.2-2010. 食品微生物学检验菌落总数测定[S].[] Zhu Zeng, Junyi Luo, Fanglei Zuo , et al. Screening for potential novel probiotic Lactobacillus strains based on high dipeptidyl peptidase IV and α-glucosidase inhibitory activity[J]. Functional Foods, 2016, 20: 486-495. DOI.org/10.1016/j.jff.2015.11.030[] Lang Guojun. screning and Isolation of α-glucosidase Inhibitor from microbial Metabolites and Inhibitor producing Strain's Identification[D]. Shanghai: Shanghai Normal University Master Dissertation, 2007: 17-18.[] Zhang J F, Zheng Y G, Shen Y C. Inhibitory effect of valienamine on the enzymatic activity of honeybee α-glucosidase[J]. Pesticide Biochemistry and Physiology, 2007, 87(1): 73-77. DOI.org/10.1016/j.pestbp.2006.06.001[] Mirzaei H. Barzgari A. Isolation and molecular study of potentially probiotic lactobacilli in traditional white cheese of Tabriz in Iran[J]. Ann. Biol. Res. 2012, 3: 2213–2216.[] Mojtaba Shakibaie, Tayebe Mohammadi-Khorsand, et al. Probiotic and antioxidant properties of selenium-enriched Lactobacillus brevis LSe isolated from an Iranian traditional dairy product[J].Trace Elements in Medicine and Biology, 2017, 40: 1-9. DOI.org/10.1016/j.jtemb.2016.11.013[] Chun-Feng Guo, Shuang Zhang, et al. Comparison of lactobacilli isolated from Chinese suan-tsai and koumiss for their probiotic and functional properties[J]. functional foods, 2015 12: 294–302. DOI.org/10.1016/j.jff.2014.11.029[] Versantvoort CHM, Oomen A G, Kamp EVd, et al. Applicability of an in vitro digestion model in assessing the bioaccessibility of mycotoxins from food[J]. Food and Chemical Toxicology, 2005, 43(1): 31-40. DOI.org/10.1016/j.fct.2004.08.007[] Guo Z, Wang J C, Yuan L Y, et al. In vitro comparison of probiotic properties of Lactobacillus casei Zhang, a potential new probiotic, with selected probiotic strains[J]. LWT- Food Science and Technology, 2009, 42(10): 1640-1646. DOI.org/10.1016/j.lwt.2009.05.025[] 陈臣, 周方方, 吴正钧, 等. 荧光标记法初探植物乳杆菌 ST-III对 Caco-2细胞的粘附机理[J]. 微生物学通报, 2010, 223(3): 355-361.[] Salminen S, Deighton M, Gorbach S. Lactic acid bacteria in health and disease[J]. Lactic acid bacteria, 1993, 58:199.[] Mitsuharu M, Hifumi O, Yoshimi B.H+-ATPase activity in Bifidobacterium with special reference to acid tolerance[J]. International Journal of Food Microbiology, 2004, 93(1) :109-113. DOI.org/10.1016/j.ijfoodmicro.2003.10.009[] 李清, 刘小莉, 王英等. 植物乳杆菌表面性质及对Caco-2细胞的黏附[J]. 食品科学, 2015, 36(9): 97-101. |